Skip to content
★ Sign in to follow
DH

David Hanuka

Executive
Cogentix Medical Inc /DE/
Total declarations
22
Company
1
▲ Purchases (11 ops.)
€52k
▼ Sales (11 ops.)
€82k

Latest filing published 11 Dec 2008 for COGENTIX MEDICAL INC /DE/, €123.

Insider track record

Disclosed buys
11
Disclosed sells
11
Signal history

No signal scores available.

Closed purchases

Market purchases
11

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

David Hanuka: trading record in brief

David Hanuka discloses dealings in Cogentix Medical Inc /DE/ to SEC (Form 4). We count 22 filings; the first trade dates from 19 August 2008 and the latest from 10 December 2008.

In open-market terms, that means 11 purchases worth €52k on one side and 11 sales worth €82k on the other. On balance, insiders were net sellers of €29k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The median purchase comes to €2,516.

The record was last updated on 11 December 2008 with an open-market purchase (€123) in Cogentix Medical Inc /DE/. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to David Hanuka

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total
  • ▲
    V.P. Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    160 USD0SEC
    100 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-076005:0
    Canonical exit: 10 Mar 2009 (T+90)
  • ▲
    VP, Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    2,920 USD0SEC
    1,825 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-076020:0
    Canonical exit: 9 Mar 2009 (T+90)
  • ▼
    V.P. Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    205 USD0SEC
    100 shares@ US$2.05Common Stock, par value $.01 per shareSEC:0001104659-08-076005:1
  • ▼
    VP, Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    3,741 USD0SEC
    1,825 shares@ US$2.05Common Stock, par value $.01 per shareSEC:0001104659-08-076020:1
  • ▲
    VP, Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    25,600 USD0SEC
    16,000 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-075721:0
    Canonical exit: 8 Mar 2009 (T+90)
  • ▼
    VP, Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    32,160 USD0SEC
    16,000 shares@ US$2.01Common Stock, par value $.01 per shareSEC:0001104659-08-075721:1
  • ▼
    V.P. Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    3,900 USD0SEC
    2,000 shares@ US$1.95Common Stock, par value $.01 per shareSEC:0001104659-08-075575:1
  • ▲
    V.P. Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    3,200 USD0SEC
    2,000 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-075575:0
    Canonical exit: 5 Mar 2009 (T+90)
  • ▼
    V.P. Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    290 USD0SEC
    132 shares@ US$2.20Common Stock, par value $.01 per shareSEC:0001104659-08-075295:1
  • ▲
    V.P. Research and DevelopmentExecutivesCogentix Medical Inc /DE/
    211 USD0SEC
    132 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-075295:0
    Canonical exit: 4 Mar 2009 (T+90)
  • ▲
    V.P., Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    20,960 USD0SEC
    13,100 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-074663:0
    Canonical exit: 3 Mar 2009 (T+90)
  • ▲
    V.P., Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    3,200 USD0SEC
    2,000 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-074663:2
    Canonical exit: 3 Mar 2009 (T+90)
  • ▼
    V.P., Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    26,200 USD0SEC
    13,100 shares@ US$2.00Common Stock, par value $.01 per shareSEC:0001104659-08-074663:1
  • ▼
    V.P., Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    4,020 USD0SEC
    2,000 shares@ US$2.01Common Stock, par value $.01 per shareSEC:0001104659-08-074663:3
  • ▼
    VP Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    788 USD0SEC
    315 shares@ US$2.50Common Stock, par value $.01 per shareSEC:0001104659-08-072058:1
  • ▲
    VP Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    504 USD0SEC
    315 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-072058:0
    Canonical exit: 16 Feb 2009 (T+90)
  • ▲
    VP, Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    3,520 USD0SEC
    2,200 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-055576:0
    Canonical exit: 24 Nov 2008 (T+90)
  • ▼
    VP, Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    9,108 USD0SEC
    2,200 shares@ US$4.14Common Stock, par value $.01 per shareSEC:0001104659-08-055576:1
  • ▲
    VP, Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    4,480 USD0SEC
    2,800 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-055388:0
    Canonical exit: 23 Nov 2008 (T+90)
  • ▼
    VP, Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    11,872 USD0SEC
    2,800 shares@ US$4.24Common Stock, par value $.01 per shareSEC:0001104659-08-055388:1
  • ▲
    VP, Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    8,000 USD0SEC
    5,000 shares@ US$1.60Common Stock, par value $.01 per shareSEC:0001104659-08-054097:0
    Canonical exit: 17 Nov 2008 (T+90)
  • ▼
    VP, Research & DevelopmentExecutivesCogentix Medical Inc /DE/
    22,550 USD0SEC
    5,000 shares@ US$4.51Common Stock, par value $.01 per shareSEC:0001104659-08-054097:1

22 of 22 declarations